×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Singleplex Immunoassay Market Share

ID: MRFR/LS/4737-HCR
100 Pages
Kinjoll Dey
October 2025

Singleplex Immunoassay Market Research Report Information By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Singleplex Immunoassay Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Singleplex Immunoassay Market Share Analysis

A successful market percentage positioning inside the Singleplex Immunoassay market starts off evolving with a complete evaluation of the present-day market landscape. Understanding the demand, competition, and emerging trends in immunoassay technologies is essential in formulating powerful strategies. Singleplex Immunoassays find programs in various fields, from medical diagnostics to pharmaceutical research. Companies must identify and goal unique packages, together with biomarker detection or ailment diagnosis, tailoring their advertising and improvement techniques accordingly. Focusing on customization for clinical diagnostics can be a key approach. Developing Singleplex Immunoassays that cater to the particular wishes of diagnostic laboratories, such as fast and correct detection of biomarkers, can appeal to healthcare specialists and institutions. Given the important nature of diagnostic applications, groups should prioritize regulatory compliance and satisfactory assurance. Adhering to strict requirements ensures the reliability and accuracy of Singleplex Immunoassays, constructing consideration among healthcare specialists and institutions. Education plays a pivotal role in the adoption of recent technology. Companies should spend money on academic tasks and schooling applications to familiarize healthcare experts with the blessings and packages of Singleplex Immunoassays, facilitating wider adoption. Pricing strategies are large in market proportion positioning. Offering price-powerful answers that are stable and affordable with high performance can entice a broader variety of customers, such as smaller laboratories and research centers. To cater to the various desires of researchers and clinicians, companies can become conscious of diversifying the to-be-had biomarker panels for Singleplex Immunoassays. Streamlining laboratory workflows is important. Companies can expand Singleplex Immunoassay structures that seamlessly integrate with laboratory records systems, supplying efficient information control and evaluation abilities for healthcare specialists. Embracing virtual health answers is a current method. Establishing a strong logo presence is key to increasing market share. Implementing targeted advertising campaigns, both online and offline, can beautify the visibility of Singleplex Immunoassay technologies. The area of immunoassays is dynamic, with constant technological improvements. Companies in the Singleplex Immunoassay market ought to stay adaptable to emerging developments, whether or not in assay codecs, detection technologies, or records evaluation methods, to stay competitive and maintain market relevance.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

At what CAGR is the Singleplex Immunoassay Market projected to grow during the forecast period?

Singleplex Immunoassay Market is projected to grow at an 10.34% CAGR between 2024-2032.

Which region is expected to lead the Singleplex Immunoassay Market?

The Americas is expected to lead the Singleplex Immunoassay Market.

What are the key factors driving the Singleplex Immunoassay Market?

Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.

Which factors may limit the Singleplex Immunoassay Market growth?

Poor healthcare system may limit market growth.

What are the different strategies used by market players to create a dominance in the Singleplex Immunoassay Market?

Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.

Market Summary

As per MRFR analysis, the Singleplex Immunoassay Market Size was estimated at 197.0 USD Million in 2024. The Singleplex Immunoassay industry is projected to grow from 203.26 in 2025 to 277.98 by 2035, exhibiting a compound annual growth rate (CAGR) of 3.18 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Singleplex Immunoassay Market is poised for substantial growth driven by technological advancements and increasing demand for personalized medicine.

  • Technological advancements are enhancing the sensitivity and specificity of singleplex immunoassays, thereby improving diagnostic accuracy.
  • The rising demand for personalized medicine is propelling the adoption of singleplex immunoassays in clinical diagnostics and research settings.
  • North America remains the largest market for singleplex immunoassays, while the Asia-Pacific region is emerging as the fastest-growing market.
  • Key market drivers include the increasing prevalence of chronic diseases and advancements in assay technologies, which are fostering innovation in diagnostic solutions.

Market Size & Forecast

2024 Market Size 197.0 (USD Million)
2035 Market Size 277.98 (USD Million)
CAGR (2025 - 2035) 3.18%
Largest Regional Market Share in 2024 North America

Major Players

<p>Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories (US), PerkinElmer (US), Quidel Corporation (US)</p>

Market Trends

The Singleplex Immunoassay Market is currently experiencing notable growth, driven by advancements in diagnostic technologies and an increasing demand for precise and rapid testing solutions. This market encompasses a variety of applications, including clinical diagnostics, research, and drug development. The rise in chronic diseases and the need for personalized medicine are further propelling the adoption of singleplex immunoassays. As healthcare systems evolve, the emphasis on early detection and monitoring of diseases becomes paramount, thereby enhancing the relevance of this market. Moreover, the Singleplex Immunoassay Market is characterized by a diverse range of players, from established companies to innovative startups. This competitive landscape fosters continuous improvement in assay sensitivity and specificity, which are critical for accurate results. Regulatory bodies are also playing a crucial role in shaping the market by establishing guidelines that ensure the reliability and safety of these diagnostic tools. As the market progresses, it appears poised for further expansion, with potential opportunities emerging in developing regions where healthcare infrastructure is improving.

Technological Advancements

Recent innovations in assay technologies are enhancing the performance of singleplex immunoassays. These advancements include improved detection methods and automation, which streamline workflows and increase throughput. As a result, laboratories can achieve faster turnaround times, meeting the growing demand for rapid diagnostics.

Rising Demand for Personalized Medicine

The shift towards personalized medicine is influencing the Singleplex Immunoassay Market significantly. Healthcare providers are increasingly seeking tailored diagnostic solutions that cater to individual patient needs. This trend is likely to drive the development of more specific assays that can provide insights into unique biological markers.

Regulatory Influence

Regulatory agencies are becoming more involved in the Singleplex Immunoassay Market, establishing stringent guidelines to ensure product quality and efficacy. This regulatory oversight is essential for maintaining public trust and safety, potentially leading to increased market stability and growth as companies adapt to these requirements.

Singleplex Immunoassay Market Market Drivers

Market Growth Projections

The Global Singleplex Immunoassay Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.2 USD Billion in 2024, it is anticipated to reach 0.28 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 3.18% from 2025 to 2035. Factors contributing to this growth include rising demand for diagnostic testing, technological advancements, and increased investment in research and development. The market's expansion is likely to be driven by the continuous evolution of healthcare needs and the increasing focus on personalized medicine.

Rising Demand for Diagnostic Testing

The Global Singleplex Immunoassay Market Industry experiences a notable surge in demand for diagnostic testing across various healthcare settings. This trend is driven by the increasing prevalence of chronic diseases and the need for early detection. For instance, the market is projected to reach 0.2 USD Billion in 2024, reflecting a growing emphasis on personalized medicine and targeted therapies. As healthcare providers seek efficient and accurate testing methods, singleplex immunoassays offer a streamlined approach to diagnostics, thereby enhancing patient outcomes. This rising demand is likely to propel the market further, as stakeholders invest in innovative technologies and solutions.

Growing Focus on Point-of-Care Testing

The growing focus on point-of-care testing significantly influences the Global Singleplex Immunoassay Market Industry. As healthcare systems strive to improve patient access to diagnostics, singleplex immunoassays offer rapid results and ease of use in diverse settings. This shift towards decentralized testing is particularly relevant in rural and underserved areas, where traditional laboratory access may be limited. The convenience and efficiency of point-of-care testing are likely to drive market growth, as healthcare providers increasingly adopt these assays to enhance patient care. This trend aligns with the broader movement towards patient-centered healthcare solutions.

Technological Advancements in Assay Development

Technological advancements play a pivotal role in shaping the Global Singleplex Immunoassay Market Industry. Innovations in assay development, such as enhanced sensitivity and specificity, are driving the adoption of singleplex immunoassays in clinical laboratories. These advancements facilitate the detection of low-abundance biomarkers, which is crucial for disease diagnosis and monitoring. As a result, the market is expected to grow, reaching 0.28 USD Billion by 2035. Furthermore, the integration of automation and digital platforms in assay processes enhances efficiency and reduces turnaround times, making singleplex immunoassays more appealing to healthcare providers.

Increased Investment in Research and Development

Investment in research and development is a significant driver of the Global Singleplex Immunoassay Market Industry. As pharmaceutical and biotechnology companies focus on developing novel therapeutics, the demand for reliable diagnostic tools becomes paramount. This trend is evidenced by the projected compound annual growth rate (CAGR) of 3.18% from 2025 to 2035. Increased funding for research initiatives fosters innovation in assay technologies, enabling the development of more precise and user-friendly singleplex immunoassays. Consequently, this investment not only enhances the capabilities of existing assays but also paves the way for new applications in various fields, including oncology and infectious diseases.

Regulatory Support for Innovative Diagnostic Solutions

Regulatory support for innovative diagnostic solutions is a crucial driver of the Global Singleplex Immunoassay Market Industry. Governments and regulatory bodies are increasingly recognizing the importance of rapid and accurate diagnostics in improving public health outcomes. Streamlined approval processes for novel assays encourage manufacturers to invest in the development of singleplex immunoassays. This supportive regulatory environment fosters innovation and competition within the market, ultimately benefiting healthcare providers and patients alike. As a result, the market is poised for growth, with an increasing number of innovative products entering the landscape.

Market Segment Insights

By Application: Clinical Diagnostics (Largest) vs. Research and Development (Fastest-Growing)

<p>In the Singleplex Immunoassay Market, the application segment is primarily dominated by Clinical Diagnostics, which accounts for a significant share due to its essential role in disease detection and monitoring. Following closely is Research and Development, particularly gaining ground as more organizations focus on innovative diagnostic solutions and methodologies. The prevalence of chronic diseases and the need for rapid testing solutions have further solidified the dominance of clinical diagnostics while expediting the growth of R&D activities. As the demand for personalized medicine and targeted therapies rises, the Research and Development application is experiencing robust growth. The pursuit of new biomarkers and the continuous evolution of technologies within immunoassay methodologies are propelling this segment forward. Moreover, the increasing focus on environmental testing due to regulatory requirements and health concerns regarding contaminants is also driving innovation and investment in R&D, thereby ensuring its position as the fastest-growing segment in the Singleplex Immunoassay Market.</p>

<p>Clinical Diagnostics (Dominant) vs. Drug Discovery (Emerging)</p>

<p>Clinical Diagnostics serves as the dominant application within the Singleplex Immunoassay Market, characterized by its extensive integration into healthcare systems, enabling efficient disease diagnosis and monitoring. This segment continuously evolves as it embraces advancements in immunoassay technologies that enhance precision and reliability. In contrast, Drug Discovery is identified as an emerging application, where companies leverage singleplex assays to facilitate early-stage research and development, accelerating the drug testing processes. This application is crucial in transforming lab findings into clinical practices, but it is still developing compared to the established practices found in clinical diagnostics. The collaboration between pharma companies and research institutions is anticipated to strengthen the position of Drug Discovery, making it increasingly competitive.</p>

By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

<p>In the Singleplex Immunoassay Market, Hospitals represent the largest segment, driven by the increasing patient inflow requiring diagnostic testing and the rising prevalence of chronic diseases. At the same time, Diagnostic Laboratories are witnessing rapid growth, fueled by advancements in technology and an increase in the adoption of innovative immunoassay techniques that improve diagnostics precision and turnaround time.</p>

<p>Hospitals (Dominant) vs. Diagnostic Laboratories (Emerging)</p>

<p>Hospitals are the dominant players in the Singleplex Immunoassay Market due to their extensive patient networks and integrated healthcare services. They benefit from established funding and resources to adopt advanced diagnostic technologies. In contrast, Diagnostic Laboratories are emerging as critical providers of specialized testing services, offering greater flexibility and quick turnaround times for immunoassay tests. This segment is capitalizing on the rising demand for precise diagnostics, particularly in specific fields like infectious diseases and personalized medicine, enabling them to establish a strong foothold in the market.</p>

By Technology: Enzyme-Linked Immunosorbent Assay (Largest) vs. Lateral Flow Assay (Fastest-Growing)

<p>The Singleplex Immunoassay Market is primarily dominated by the Enzyme-Linked Immunosorbent Assay (ELISA), which holds a significant share due to its extensive application in diagnostics and research. Following ELISA, the Lateral Flow Assay is gaining traction, particularly in point-of-care testing, which has propelled its market presence. Other technologies such as Fluorescent and Chemiluminescent Immunoassays contribute to the overall diversity of the market but are currently overshadowed by these two leading methodologies. Growth trends in this segment indicate a continuous upward trajectory for lateral flow assays, driven by the demand for rapid and reliable testing solutions. Technological advancements and increasing investment in healthcare infrastructure further serve as catalysts for the growth of these immunoassays. Additionally, the rising prevalence of infectious diseases and chronic conditions emphasizes the need for innovative diagnostic tools, providing a robust environment for both established and emerging technologies to thrive.</p>

<p>Technology: ELISA (Dominant) vs. Lateral Flow Assay (Emerging)</p>

<p>The Enzyme-Linked Immunosorbent Assay (ELISA) is recognized as the dominant player in the Singleplex Immunoassay Market, characterized by its versatility, high sensitivity, and wide range of applications, including disease diagnosis and research. It employs enzyme-labeled antibodies to detect specific antigens, allowing for quantitative and qualitative analysis. On the other hand, the Lateral Flow Assay is emerging due to its ease of use, speed, and adaptability to a variety of conditions. Its ability to deliver rapid results without the need for specialized equipment makes it increasingly popular, especially in remote or resource-limited settings. This emerging segment, with its unique advantages, is poised to capture a larger share of the market as healthcare systems evolve.</p>

By Product Type: Kits (Largest) vs. Reagents (Fastest-Growing)

<p>The Singleplex Immunoassay Market exhibits a distinct distribution in market share among various product types. Kits currently dominate the market, holding the largest share due to their comprehensive nature, which simplifies workflows for laboratories. Reagents follow closely, comprising a significant portion of market transactions as they are essential components in the immunoassay process. Instruments and software solutions, though vital for the operational efficacy of immunoassays, hold smaller shares in comparison as they cater to more specialized segments of the market.</p>

<p>Kits (Dominant) vs. Reagents (Emerging)</p>

<p>Kits in the Singleplex Immunoassay Market are celebrated for their all-in-one convenience, appealing to laboratories seeking efficiency and ease in test execution. They typically include all necessary components, allowing for quicker diagnostic processes. In contrast, reagents represent an emerging and vital segment, driving continuous innovation in assay development. As research progresses, the need for specialized and high-quality reagents is rapidly increasing. This surge is propelled by an expanding research landscape focused on personalized medicine, suggesting that while kits remain dominant, reagents are evolving to become indispensable components of modern diagnostic procedures.</p>

By Target Analyte: Proteins (Largest) vs. Antibodies (Fastest-Growing)

<p>In the Singleplex Immunoassay Market, the segment of proteins holds the largest market share, reflecting its significance in various applications such as diagnostics and therapeutics. Hormones and pathogens also contribute to the market, though to a lesser extent, demonstrating the diverse range of target analytes used in immunoassays. Antibodies, while smaller in share, are gaining momentum and are critical for advanced diagnostic methodologies.</p>

<p>Proteins: Dominant vs. Antibodies: Emerging</p>

<p>Proteins, as a dominant target analyte in the Singleplex Immunoassay Market, are extensively utilized for their critical role in disease diagnosis and monitoring. Their well-established applications make them a staple in laboratories. On the other hand, antibodies represent an emerging segment, rapidly gaining traction due to advancements in immunoassay technologies. The prevalence of antibody-based tests in research and clinical diagnostics exemplifies their growth, driven by increasing R&D and the demand for specific targeting in disease detection.</p>

Get more detailed insights about Singleplex Immunoassay Market Research Report – Forecast to 2035

Regional Insights

Key Players and Competitive Insights

The Singleplex Immunoassay Market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Abbott Laboratories (US), Roche Diagnostics (CH), and Thermo Fisher Scientific (US) are at the forefront, leveraging their extensive research capabilities and technological advancements to enhance product offerings. Abbott Laboratories (US) focuses on expanding its diagnostic portfolio through strategic acquisitions, while Roche Diagnostics (CH) emphasizes innovation in assay development, particularly in personalized medicine. Thermo Fisher Scientific (US) appears to be concentrating on digital transformation initiatives, integrating advanced data analytics into their immunoassay platforms, which collectively enhances their competitive positioning in the market.

The market structure is moderately fragmented, with a mix of established players and emerging companies vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of global economic fluctuations. The collective influence of these major players fosters a dynamic environment where innovation and operational efficiency are paramount, driving overall market growth.

In November 2025, Roche Diagnostics (CH) announced the launch of a new singleplex immunoassay that utilizes cutting-edge biomarker technology to improve diagnostic accuracy. This strategic move is significant as it not only enhances Roche's product portfolio but also positions the company as a leader in precision diagnostics, potentially increasing its market share in a competitive landscape.

In October 2025, Abbott Laboratories (US) entered into a partnership with a leading biotechnology firm to co-develop next-generation immunoassays aimed at chronic disease management. This collaboration is likely to bolster Abbott's innovation pipeline and expand its reach into new therapeutic areas, reflecting a strategic focus on addressing unmet medical needs.

In September 2025, Thermo Fisher Scientific (US) unveiled a new cloud-based platform designed to streamline data management for immunoassay testing. This initiative not only enhances operational efficiency but also aligns with the growing trend of digitalization in healthcare, suggesting that Thermo Fisher is positioning itself to capitalize on the increasing demand for integrated laboratory solutions.

As of December 2025, the competitive trends in the Singleplex Immunoassay Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into diagnostic processes. Strategic alliances are becoming increasingly vital, as companies seek to leverage complementary strengths to enhance their market offerings. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is evident, indicating that future competitive differentiation will hinge on the ability to deliver advanced, reliable, and efficient diagnostic solutions.

Key Companies in the Singleplex Immunoassay Market market include

Industry Developments

Future Outlook

Singleplex Immunoassay Market Future Outlook

<p>The Singleplex Immunoassay Market is projected to grow at a 3.18% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for diagnostics, and rising healthcare expenditures.</p>

New opportunities lie in:

  • <p>Development of portable immunoassay devices for point-of-care testing.</p>
  • <p>Integration of AI for enhanced data analysis and result interpretation.</p>
  • <p>Expansion into emerging markets with tailored diagnostic solutions.</p>

<p>By 2035, the Singleplex Immunoassay Market is expected to achieve robust growth and increased market penetration.</p>

Market Segmentation

Singleplex Immunoassay Market End Use Outlook

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Academic Institutions

Singleplex Immunoassay Market Technology Outlook

  • Enzyme-Linked Immunosorbent Assay
  • Lateral Flow Assay
  • Fluorescent Immunoassay
  • Chemiluminescent Immunoassay

Singleplex Immunoassay Market Application Outlook

  • Clinical Diagnostics
  • Research and Development
  • Drug Discovery
  • Environmental Testing

Singleplex Immunoassay Market Product Type Outlook

  • Kits
  • Reagents
  • Instruments
  • Software

Singleplex Immunoassay Market Target Analyte Outlook

  • Proteins
  • Hormones
  • Antibodies
  • Pathogens

Report Scope

MARKET SIZE 2024197.0(USD Million)
MARKET SIZE 2025203.26(USD Million)
MARKET SIZE 2035277.98(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)3.18% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledAbbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Ortho Clinical Diagnostics (US), Bio-Rad Laboratories (US), PerkinElmer (US), Quidel Corporation (US)
Segments CoveredApplication, End Use, Technology, Product Type, Target Analyte
Key Market OpportunitiesAdvancements in biomarker discovery enhance diagnostic capabilities within the Singleplex Immunoassay Market.
Key Market DynamicsTechnological advancements drive innovation in Singleplex Immunoassays, enhancing diagnostic accuracy and efficiency across various applications.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

At what CAGR is the Singleplex Immunoassay Market projected to grow during the forecast period?

Singleplex Immunoassay Market is projected to grow at an 10.34% CAGR between 2024-2032.

Which region is expected to lead the Singleplex Immunoassay Market?

The Americas is expected to lead the Singleplex Immunoassay Market.

What are the key factors driving the Singleplex Immunoassay Market?

Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.

Which factors may limit the Singleplex Immunoassay Market growth?

Poor healthcare system may limit market growth.

What are the different strategies used by market players to create a dominance in the Singleplex Immunoassay Market?

Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&amp;D.

  1. Definition
    1. Scope of the Study
      1. Research
      2. Assumptions
      3. Limitations
    2. Introduction
    3. Primary Research
    4. Secondary Research
    5. Market Size Estimation
    6. Drivers
    7. Restraints
    8. Opportunities
    9. Challenges
    10. Macroeconomic
    11. Technology Trends & Assessment
    12. Porter’s Five Forces Analysis
      1. Bargaining Power
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    13. Value Chain
    14. Investment Feasibility Analysis
    15. Pricing Analysis
  2. Global Singleplex Immunoassay Market, by Product and Service
    1. Introduction
    2. Consumables
  3. Market Estimates & Forecast, by Region, 2022-2030
  4. Market Estimates & Forecast, by Country, 2022-2030
    1. Instruments
  5. Market Estimates & Forecast, by Region, 2022-2030
    1. Market Estimates &
    2. Forecast, by Country, 2022-2030
    3. Others
    4. Market Estimates & Forecast,
    5. by Region, 2022-2030
  6. Market Estimates & Forecast, by Country, 2022-2030
  7. Chapter 7. Global Singleplex Immunoassay Market, by Type
    1. Introduction
    2. Protein-Based Assays
  8. Market Estimates & Forecast, by Region, 2022-2030
  9. Market Estimates & Forecast, by Country, 2022-2030
    1. Nucleic Acid Based
    2. Assays
  10. Market Estimates & Forecast, by Region, 2022-2030
    1. Market Estimates
    2. & Forecast, by Country, 2022-2030
    3. Cell-Based Assays
    4. Market Estimates
    5. & Forecast, by Region, 2022-2030
  11. Market Estimates & Forecast, by Country,
    1. Others
  12. Market Estimates & Forecast, by Region, 2022-2030
  13. Market Estimates & Forecast, by Country, 2022-2030
    1. Chapter 8. Global
  14. Singleplex Immunoassay Market, by Technology
    1. Introduction
    2. Flow
    3. Cytometry
  15. Market Estimates & Forecast, by Region, 2022-2030
    1. Market
    2. Estimates & Forecast, by Country, 2022-2030
    3. Fluorescence Detection
  16. Market Estimates & Forecast, by Region, 2022-2030
    1. Market Estimates &
    2. Forecast, by Country, 2022-2030
    3. Others
    4. Market Estimates & Forecast,
    5. by Region, 2022-2030
  17. Market Estimates & Forecast, by Country, 2022-2030
  18. Chapter 9. Global Singleplex Immunoassay Market, by Application
    1. Introduction
    2. Research & Development
      1. Drug Discovery & Development
  19. Market Estimates & Forecast, by Region, 2022-2030
    1. Market Estimates &
    2. Forecast, by Country, 2022-2030
  20. Biomarker Discovery & validation
  21. Market Estimates & Forecast, by Region, 2022-2030
    1. Market Estimates &
    2. Forecast, by Country, 2022-2030
    3. Clinical Diagnostics
      1. Infectious
    4. Diseases
  22. Market Estimates & Forecast, by Region, 2022-2030
    1. Market
    2. Estimates & Forecast, by Country, 2022-2030
    3. Market Estimates
    4. & Forecast, by Region, 2022-2030
  23. Cancer
  24. Market Estimates & Forecast, by Country,
    1. Market Estimates & Forecast,
    2. by Region, 2022-2030
  25. Cardiovascular Diseases
  26. Market Estimates & Forecast, by Country, 2022-2030
  27. Autoimmune Diseases
  28. Market Estimates & Forecast, by Region, 2022-2030
  29. Market Estimates & Forecast, by Country, 2022-2030
    1. Disorders
  30. Nervous System
  31. Market Estimates & Forecast, by Region, 2022-2030
    1. Market
    2. Estimates & Forecast, by Country, 2022-2030
    3. Disorders
  32. Metabolism & Endocrinology
  33. Market Estimates & Forecast, by Region, 2022-2030
    1. Market
    2. Estimates & Forecast, by Country, 2022-2030
    3. Others
    4. Market Estimates
    5. & Forecast, by Region, 2022-2030
  34. Market Estimates & Forecast, by Country,
  35. Chapter 10. Global Singleplex Immunoassay Market, by End-User
    1. Introduction
    2. Pharmaceuticals & Biotechnology Companies
    3. Market
    4. Estimates & Forecast, by Region, 2022-2030
    5. Market Estimates & Forecast,
    6. by Country, 2022-2030
    7. Hospital & Research Institutes
    8. Market Estimates
    9. & Forecast, by Region, 2022-2030
  36. Market Estimates & Forecast, by Country,
    1. Reference Laboratories
    2. Market Estimates & Forecast,
    3. by Region, 2022-2030
  37. Market Estimates & Forecast, by Country, 2022-2030
    1. Others
  38. Market Estimates & Forecast, by Region, 2022-2030
    1. Market
    2. Estimates & Forecast, by Country, 2022-2030
    3. Chapter 11. Global Singleplex
  39. Immunoassay Market, by Region
    1. Introduction
    2. Americas
    3. North America
    4. Europe
    5. China
    6. Rest of Asia Pacific
    7. East
    8. Chapter 12. Company Landscape
    9. Chapter
  40. US
  41. Canada
  42. South America
    1. Europe
      1. Western Europe
      2. Eastern Europe
    2. Asia Pacific
      1. Japan
      2. India
      3. Australia
      4. Republic of Korea
    3. The Middle East & Africa
      1. The Middle
      2. Africa
    4. Introduction
    5. Market Share Analysis
    6. Key Development & Strategies
  43. Company Profiles
    1. Luminex
      1. Company Overview
      2. Financials Overview
      3. Key Developments
      4. SWOT Analysis
    2. Product Overview
    3. Thermo Fisher Scientific
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    4. Illumina
      1. Company Overview
      2. Financial Overview
      3. Key Development
    5. Product Overview
    6. SWOT Analysis
    7. Bio-Rad Laboratories
      1. Company Overview
      2. Financial Overview
      3. SWOT Analysis
    8. Technology/Business Segment Overview
    9. Key Development
    10. QIAGEN N. V
      1. Company
      2. Product Overview
      3. Financial overview
      4. SWOT Analysis
    11. Overview
    12. Key Developments
    13. Abcam
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    14. Becton Dickinson and Company
      1. Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    15. Merck Life Sciences
      1. Overview
      2. Financials
      3. Key Developments
      4. SWOT Analysis
    16. Product/ Technology Overview
    17. Agilent Technologies
      1. Overview
      2. Financials
      3. Key Developments
    18. Product Overview
    19. SWOT Analysis
    20. Quanterix
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    21. Bio-Techne
      1. Overview
      2. Product Overview
      3. Key Developments
      4. SWOT Analysis
    22. Financials
    23. Olink
      1. Overview
      2. Product Overview
      3. Financials
      4. SWOT Analysis
    24. Key Developments
    25. Seegene
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    26. BioVendor
      1. Overview
      2. Financials
      3. Key Developments
    27. Product Overview
    28. SWOT Analysis
    29. Others
    30. Chapter 14 MRFR Conclusion
    31. Key Findings
      1. From CEO’s View Point
      2. Unmet Needs of the Market
    32. Key Companies to Watch
    33. Prediction of the Arthroscopy Instruments Industry
    34. Chapter 15 Appendix
  44. LIST OF TABLES
  45. Global Singleplex
    1. Immunoassay Market Synopsis, 2022-2030
  46. Global Singleplex Immunoassay
    1. Market Estimates and Forecast, 2022-2030, (USD
    2. Million)
  47. Global
  48. Singleplex Immunoassay Market, by Region, 2022-2030, (USD Million)
    1. Table 4
  49. Global Singleplex Immunoassay Market, by Product and Service, 2022-2030, (USD
    1. Million)
  50. Global Singleplex Immunoassay Market, by Type, 2022-2030,
    1. (USD Million)
  51. Global Singleplex Immunoassay Market, by Technology,
  52. Global Singleplex Immunoassay Market, by Application,
  53. Global Singleplex Immunoassay Market, by End-User,
  54. North America Global Singleplex Immunoassay
  55. Market, by Product and Service, 2018–
    1. Table
  56. North America Global Singleplex Immunoassay Market, by Type, 2022-2030, (USD
    1. Million)
  57. North America Global Singleplex Immunoassay Market, by
    1. Technology, 2022-2030, (USD
    2. Million)
  58. North America Global Singleplex
  59. Immunoassay Market, by Application, 2022-2030, (USD
    1. Million)
    2. Table 13
  60. North America Global Singleplex Immunoassay Market, by End-User, 2022-2030, (USD
    1. Million)
  61. US Singleplex Immunoassay Market, by Product and Service,
  62. US Singleplex Immunoassay Market, by Type,
  63. US Singleplex Immunoassay Market, by Technology,
  64. US Singleplex Immunoassay Market, by Application,
  65. US Singleplex Immunoassay Market, by End-User,
  66. Canada Singleplex Immunoassay Market, by
    1. Product and Service, 2022-2030, (USD
    2. Million)
  67. Canada Singleplex
  68. Immunoassay Market, by Type, 2022-2030, (USD Million)
  69. Canada Singleplex
  70. Immunoassay Market, by Technology, 2022-2030, (USD Million)
  71. Canada
  72. Singleplex Immunoassay Market, by Application, 2022-2030, (USD Million)
    1. Table
  73. Canada Singleplex Immunoassay Market, by End-User, 2022-2030, (USD Million)
  74. South America Singleplex Immunoassay Market, by Product and Service,
    1. (USD Million)
  75. South America Singleplex Immunoassay
  76. Market, by Type, 2022-2030, (USD Million)
  77. South America Singleplex
  78. Immunoassay Market, by Technology, 2022-2030, (USD
    1. Million)
  79. South
  80. America Singleplex Immunoassay Market, by Application, 2022-2030, (USD
    1. Million)
  81. South America Singleplex Immunoassay Market, by End-User, 2022-2030,
    1. (USD Million)
  82. Europe Singleplex Immunoassay Market, by Product and
    1. Service, 2022-2030, (USD
    2. Million)
  83. Europe Singleplex Immunoassay
  84. Market, by Type, 2022-2030, (USD Million)
  85. Europe Singleplex Immunoassay
  86. Market, by Technology, 2022-2030, (USD Million)
  87. Europe Singleplex
  88. Immunoassay Market, by Application, 2022-2030, (USD Million)
  89. Europe
  90. Singleplex Immunoassay Market, by End-User, 2022-2030, (USD Million)
    1. Table
  91. Western Europe Singleplex Immunoassay Market, by Product and Service, 2022-2030,
    1. (USD Million)
  92. Western Europe Singleplex Immunoassay Market, by Type,
  93. Western Europe Singleplex Immunoassay Market,
    1. by Technology, 2022-2030, (USD
    2. Million)
  94. Western Europe Singleplex
  95. Immunoassay Market, by Application, 2022-2030, (USD
    1. Million)
    2. Table 38
  96. Western Europe Singleplex Immunoassay Market, by End-User, 2022-2030, (USD
    1. Million)
  97. Eastern Europe Singleplex Immunoassay Market, by Product and Service,
    1. (USD Million)
  98. Eastern Europe Singleplex Immunoassay
  99. Market, by Type, 2022-2030, (USD Million)
  100. Eastern Europe Singleplex
  101. Immunoassay Market, by Technology, 2022-2030, (USD
    1. Million)
  102. Eastern
  103. Europe Singleplex Immunoassay Market, by Application, 2022-2030, (USD
    1. Million)
  104. Eastern Europe Singleplex Immunoassay Market, by End-User, 2022-2030,
    1. (USD
    2. Million)
  105. Asia Pacific Singleplex Immunoassay Market, by
    1. Product and Service, 2022-2030, (USD
    2. Million)
  106. Asia Pacific Singleplex
  107. Immunoassay Market, by Type, 2022-2030, (USD Million)
  108. Asia Pacific
  109. Singleplex Immunoassay Market, by Technology, 2022-2030, (USD Million)
    1. Table
  110. Asia Pacific Singleplex Immunoassay Market, by Application, 2022-2030, (USD Million)
  111. Asia Pacific Singleplex Immunoassay Market, by End-User, 2022-2030, (USD
    1. Million)
  112. Middle East & Africa Singleplex Immunoassay Market, by
    1. Product and Service, 2018–
  113. Middle East
  114. & Africa Singleplex Immunoassay Market, by Type, 2022-2030, (USD
    1. Million)
  115. Middle East & Africa Singleplex Immunoassay Market, by Technology,
    1. Million)
  116. Middle East & Africa Singleplex
  117. Immunoassay Market, by Application, 2022-2030, (USD
    1. Million)
    2. Table 53
  118. Middle East & Africa Singleplex Immunoassay Market, by End-User, 2022-2030,
    1. (USD Million)
    2.  
  119. LIST OF FIGURES
  120. Research Process
  121. Segmentation for Global Singleplex Immunoassay Market
  122. Segmentation
    1. Market Dynamics for Global Singleplex Immunoassay Market
  123. Global Singleplex
  124. Immunoassay Market Share, by Product and Service 2022
  125. Global Singleplex
  126. Immunoassay Market Share, by Type 2022
  127. Global Singleplex Immunoassay
  128. Market Share, by Technology 2022
  129. Global Singleplex Immunoassay Market
    1. Share, by Application 2022
  130. Global Singleplex Immunoassay Market Share,
    1. by End-User, 2022
  131. Global Singleplex Immunoassay Market Share, by Region,
  132. North America Singleplex Immunoassay Market Share, by Country,
  133. Europe Singleplex Immunoassay Market Share, by Country, 2022
  134. Asia Pacific Singleplex Immunoassay Market Share, by Country, 2022
  135. Middle East & Africa Singleplex Immunoassay Market Share, by Country,
  136. Global Singleplex Immunoassay Market: Company Share Analysis,
  137. Luminex: Key Financials
  138. Luminex: Segmental
    1. Revenue
  139. Luminex: Geographical Revenue
  140. Thermo Fisher
    1. Scientific: Key Financials
  141. Thermo Fisher Scientific: Segmental Revenue
  142. Thermo Fisher Scientific: Geographical Revenue
  143. Illumina::Key
    1. Financials
  144. Illumina: Segmental Revenue
  145. Illumina: Geographical
    1. Revenue
  146. Bio-Rad Laboratories: Key Financials
  147. Bio-Rad
    1. Laboratories: Segmental Revenue
  148. Bio-Rad Laboratories: Geographical
    1. Revenue
  149. QIAGEN N. V:Key Financials
  150. QIAGEN N. V: Segmental
    1. Revenue
  151. QIAGEN N. V. Geographical Revenue
  152. Abcam: Key
    1. Financials
  153. Abcam: Segmental Revenue
  154. Abcam: Geographical
    1. Revenue
  155. Becton Dickinson and Company: Key Financials
    1. Figure
  156. Becton Dickinson and Company: Segmental Revenue
  157. Becton Dickinson
    1. and Company: Geographical Revenue
  158. Merck Life Sciences: Key Financials
  159. Merck Life Sciences: Segmental Revenue
  160. Merck Life Sciences:
    1. Geographical Revenue
  161. Agilent Technologies: Key Financials
    1. Figure
  162. Agilent Technologies: Segmental Revenue
  163. Agilent Technologies:
    1. Geographical Revenue
  164. Quanterix: Key Financials
  165. Quanterix:
    1. Segmental Revenue
  166. Quanterix: Geographical Revenue
    1. Figure 45
    2. Bio-Techne: Key Financials
  167. Bio-Techne: Segmental Revenue
    1. Figure
  168. Bio-Techne: Geographical Revenue
  169. Olink: Key Financials
    1. Figure
  170. Olink: Segmental Revenue
  171. Olink: Geographical Revenue
    1. Figure
  172. Seegene: Key Financials
  173. Seegene: Segmental Revenue
    1. Figure
  174. Seegene: Geographical Revenue
  175. BioVendor: Key Financials
    1. Figure
  176. BioVendor: Segmental Revenue
  177. BioVendor: Geographical Revenue

Singleplex Immunoassay Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓